| |
Lasting Correction of Skin Defects and Wrinkles
ArteSense – Breakthrough soft tissue augmentation technology
| · |
PMMA (polymethyl methacrylate) microspheres. |
| · |
Suspension polymerization for absolutely round and smooth surfaces1. |
| · |
Uniform PMMA microsphere diameter of 32 – 40 m |
| · |
Blended with partly denatured 3.5% collagen (non-sensitizing atelo-collagen) and 0.3% lidocaine for reduction of post-treatment discomfort.
| |
|
|
|
PMMA (polymethyl methacrylate) was first discovered in Germany in 1902 by the chemist O. Röhm and was patented in 1928. The first medical use of PMMA was in 1936 as dental prostheses. It has since been extensively used in a variety of medical procedures, more notably as bone replacement of the jaw and hip.
| |
|
|
ArteSense – Innovative technology with a proven history
| · |
PMMA medical use as implants dates back to 19362. |
| · |
Common medical uses of PMMA include bone cement (Palacos® and others), dentures, artificial eye lenses, pacemakers (Lucite®, Palavit® and others). |
| · |
First use for tissue augmentation in 1989. |
| · |
More than 150,000 men and women around the world have been successfully treated with Artecoll / ArteSense over the past 10 years. |
|
|
Long-lasting Youthful Skin is no Longer Just a Dream
|
|
|
|
ArteSense – Unique technology, simple application
| · |
Injection should be strictly deep dermal, via the tunneling technique. |
| · |
Although an intradermal test injection may be considered, it is not strictly necessary due to the extremely low incidence of sensitivity (<0.1%). |
| · |
ArteSense’s collagen vehicle is degraded normally within 1-3 months. |
| · |
PMMA microspheres are naturally encapsulated (within 2-4 months) through the formation of connective tissue, preventing migration.1 |
| · |
The skin defect is naturally filled by the body’s own collagen tissue, encapsulating and anchoring the PMMA microspheres. | | |
|
ArteSense – Many practical applications
| · |
Filling folds and wrinkles of the face. |
| · |
Correction of irregularities of the nose. |
| · |
Correction of acne scars. |
| · |
Augmentation of the nipple.
| |
|
Make Their Dreams of Youthful Skin a Lasting Reality ArteSense – Satisfying, long-lasting youthful skin
| · |
89.5% of patients satisfied with cosmetic results.2 |
| · |
Virtually 100% of patients had objective improvement upon post-operative review.2 |
| · |
Most patients required only one (62%) or two (24%) applications.2 |
| · |
Unlike collagen and hyaluronic acid, ArteSense maintains its cosmetic results for years. |
| · |
Your patients’ smiles will be your best advertisement.
| 
|
|
|
|
|
ArteSense – The results sell themselves
| · |
Long-lasting results imply a more satisfied patient and an increased potential for additional procedures. |
| · |
The majority of patients (86%) require a maximum of two applications.2 |
| · |
Average requirement per patient is 1.0 mL (glabellar frowns, nasolabial folds). |
| · |
Supplied as 4 x 0.7 mL syringes. |
| · |
Also available, 2 x 0.2 mL test syringes (for optional pre-treatment sensitivity). |
| · |
Advantageous for you and an excellent value for your patients. |
Long-lasting beauty is no longer just a dream |
|
Differences you’ll appreciate
| · |
An inert and totally biocompatible substance for long-lasting correction of wrinkles and other skin defects. |
| · |
Easily administered under normal in-office conditions. |
| · |
Extremely high levels of patient satisfaction. |
| · |
Minimal side effects compared to collagen and other treatments.* |
| · |
Advantageous and economical for both you and your patient.
| |
|
Supported by the Canderm Pharma Inc. commitment
| · |
Continuing Medical Education sessions to allow development of hands-on familiarity with ArteSense. |
| · |
A dedicated ArteSense information line for both clinicians and patients at
1 877 278-3265 or 514-334-3830 in Montreal. |
| · |
Co-op advertising available to support ArteSense initiatives. |
| · |
A full line of cosmetic medicine products to meet your needs and the needs of your patients. |
* Less than 0.1% sensitivity has been reported. Slight redness and swelling may be present for 1 – 2 days.3 |
|
|
References:
1. Hertzog B.J Med Esth and Chir Derm, 1996; 24: 253-257.
2. Lemperle G, et al. Plast Reconstr Surg 1995; 96: 627-634.
3. ArteSense HPB-approved Product Description, Canderm Pharma Inc.
|